SCHEMBL7774201

SCHEMBL7774201

COc1cc(CN(Cc2ccc(O)c(OC)c2)C(=O)CCCCCCCC(N)=O)ccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.52
CYP3A4 P08684 3/20 0.52
CYP2C9 P11712 3/20 0.52
CYP2C19 P33261 3/20 0.52
CYP2C8 P10632 1/20 0.52
CYP2B6 P20813 1/20 0.52
ALOX5 P09917 2/20 0.50
ALDH1A1 P00352 2/20 0.50
CYP2D6 P10635 2/20 0.50
BLM P54132 2/20 0.50
PMP22 Q01453 2/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 3/20 0.49
OR51E2 Q9H255 1/20 0.49
GAA P10253 1/20 0.49
NFKB1 P19838 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28400947 0.90 CYP3A4 (0.65) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL28386231 0.90 CYP3A4 (0.65) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL11575857 0.85 ALOX5 (0.66) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL28378162 0.85 ALOX5 (0.66) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL2683415 0.85 ALOX5 (0.66) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL906528 0.84 ALOX5 (0.67) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL5723843 0.82 ALOX5 (0.66) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL28894778 0.79 CYP3A4 (0.58) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL28894516 0.79 CYP3A4 (0.58) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL7795393 0.79 CYP3A4 (0.64) CYP1A2CYP3A4CYP2C9CYP2C19CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115392-A2 USE OF N-ACYLVANILLINAMIDE DERIVATIVES AS AGONISTS OF PERIPHERAL CANNABINOID CB1 RECEPTORS Innovet Italia S.r.l. (IT) 2001-07-18 EP disclosed
WO-2000016756-A2 USE OF N-ACYLVANILLINAMIDE DERIVATIVES AS AGONISTS OF PERIPHERAL CANNABINOID CB1 RECEPTORS INNOVET ITALIA S.R.L. (IT) 2000-03-30 WO disclosed